How MedTech companies decide when to patent device innovation and when to rely on trade secret protection, balancing enforcement leverage, disclosure risk, and reverse engineering realities.
Speaker(s):
Gabriel Olander
Associate GC, IP Strategy
Intuitive
Michael Doyle
Chief IP Officer
ICU Medical
Agenda Track No.:
Track 1
Session Type:
Workshop
Force Inline Description:
0